GeneDx Holdings Overview
GeneDx Holdings Target Price
Analysts' 12-month price predictions for WGS.
Get informed when a big investor buys or sells
+ FollowShare Price
$53.02
Average Target Price
$105.00
98% upside
98% upside9 analysts in the last 4 months
High: $170 | Low: $70
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-05 | Craig-HallumBill Bonello | $85 | 60.3% upside |  |
| 2026-05-05 | BTIG | $90 | 69.7% upside | |
| 2026-05-05 | Guggenheim | $70 | 32% upside | |
| 2026-05-05 | Canaccord GenuityKyle Mikson | $75 | 41.5% upside | |
| 2026-05-05 | Wells FargoBrandon Couillard | $75 | 41.5% upside | |
| 2026-04-20 | Canaccord Genuity | $100 | 88.6% upside | |
| 2026-02-24 | BTIGMark Massaro | $170 | 220.6% upside | |
| 2026-02-24 | Piper SandlerDavid Westenberg | $130 | 145.2% upside | |
| 2026-02-23 | Jefferies | $150 | 182.9% upside | |
| 2025-12-22 | Canaccord Genuity | $170 | 220.6% upside | |
| 2025-12-15 | Wells Fargo | $155 | 192.3% upside | |
| 2025-12-12 | BTIG | $200 | 277.2% upside | |
| 2025-10-29 | BTIG | $165 | 211.2% upside | |
| 2025-10-29 | Canaccord Genuity | $160 | 201.8% upside | |
| 2025-10-29 | Guggenheim | $170 | 220.6% upside | |
| 2025-10-20 | Canaccord Genuity | $155 | 192.3% upside | |
| 2025-08-04 | Piper Sandler | $120 | 126.3% upside | |
| 2024-10-24 | Craig-HallumBill Bonello | $70 | 32% upside | |
| 2024-08-27 | Wells FargoBrandon Couillard | $34 |  35.9% downside | |
| 2024-07-31 | BTIGMark Massaro | $45 | 15.1% downside | |
| 2024-07-10 | Craig-HallumBill Bonello | $43 | 18.9% downside | |
| 2024-06-26 | BTIGMark Massaro | $35 | 34% downside | |
| 2024-06-03 | JefferiesTycho Peterson | $21 | 60.4% downside | |
| 2024-04-30 | BTIGMark Massaro | $19 | 64.2% downside | |